期刊文献+

麝香保心丸联合丹七散治疗不稳定性心绞痛50例 被引量:3

Fifty Cases with Unstable Angina Treated with Shexiang Baoxin Pills Combined with Danqi Powder
下载PDF
导出
摘要 目的:观察麝香保心丸联合丹七散治疗不稳定性心绞痛的疗效价值。方法:选取不稳定性心绞痛患者100例,随机分为治疗组和对照组,每组50例。对照组给予硝酸异山梨酯片治疗,治疗组给予麝香保心丸联合自拟丹七散治疗。结果:治疗组有效率为84.0%,对照组有效率为60.0%,治疗组优于对照组(P<0.05)。结论:麝香保心丸联合丹七散治疗不稳定性心绞痛疗效显著。 Objective: To observe the efficacy value of Shexiang Baoxin Pills Combined with Danqi Powder for treating unstable angina. Methods: 100 cases with unstable angina were selected and randomized into treatment group and control group,with 50 cases in each group. Control group were given Isosorbide Dinitrate while treatment group were given Shexiang Baoxin Pills Combined with Danqi Powder for the treatment. Results: The effective rate was 84. 0% in treatment group and 60. 0% in control group; treatment group were better than control group( P 〈0. 05). Conclusion: Shexiang Baoxin Pills Combined with Danqi Powder has remarkable therapeutic effects on unstable angina.
作者 朱晨
机构地区 驻马店市中医院
出处 《河南中医》 2015年第9期2077-2078,共2页 Henan Traditional Chinese Medicine
关键词 不稳定性心绞痛 麝香保心丸 丹七散 unstable angina Shexiang Baoxin Pills Danqi Powder
  • 相关文献

参考文献5

二级参考文献28

  • 1张庆民,李娜.左卡尼汀的临床应用进展[J].齐鲁药事,2004,23(5):39-40. 被引量:10
  • 2贾连旺,杜永远.麝香保心丸对颈动脉粥样硬化的治疗作用[J].中成药,2004,26(B12):36-39. 被引量:18
  • 3王受益,戴瑞鸿,金椿,罗海明,陈曙霞,陈美芳,徐济民,郑慧君,荣烨之,赵美华,胡婉英,徐雅民.麝香保心丸治疗冠心病心绞痛的临床观察[J].中国中西医结合杂志,1996,16(12):717-720. 被引量:96
  • 4赵益业,林晓忠,张敏州,邹旭,吴焕林,李健,潘光明,邓铁涛.邓铁涛教授以心脾相关学说诊治冠心病经验介绍[J].新中医,2007,39(4):5-6. 被引量:119
  • 5国际心脏病学会和协会及世界卫生组织临床命名标准化联合专题组.缺血性心脏病的命名及诊断标准[J].中华心血管病杂志,1981,9(2):75-75.
  • 6Celermajar D S, Sorensen K E, Gooch V M, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis [ J ]. Lancet, 1992,340 : 1111-1115.
  • 7Leakukis J P, Papamichael C M, Vemmos C N, et al. peripheral vascular endothelial dysfunction in patients with pectoris and normal coronary arterograrns [ J ]. J Am Coll Cardiol , 1998,31 : 541 - 546.
  • 8Harrison D G. Endothelial dysfunction in atherosclerosis[ J]. Basic Res Cardiol , 1994,89(suppl 1 ):87-102.
  • 9Blann A D, Taberner D A. A reliable marker of endothelial cell dysfunction Dose it exist [ J ]. Br J Haematol, 1995,90 (2) :244- 248.
  • 10Joannides R, Haefeli W E, Linder L, et al, Nitric oxide is responsible for Flow-dependent dilatation of human peripheral conduit arteries in vivo[J]. Circulation,1991,91:1314.

共引文献69

同被引文献25

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部